References
- Zambia to receive 8.7 million doses of COVID-19 vaccines under AU initiative. Alliance for Science. https://allianceforscience.cornell.edu/blog/2021/01/zambia-to-receive-8-7-million-doses-of-covid-19-vaccines-under-au-initiative/ .
- Goldman RD, Yan TD, Seiler M, Parra Cotanda C, Brown JC, Klein EJ, Hoeffe J, Gelernter R, Hall JE, Davis AL, et al. Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey. Vaccine. 2020;38(48):7668–73. doi:10.1016/j.vaccine.2020.09.084.
- Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
- Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults. Ann Intern Med. 2020;173:964–73. doi:10.7326/M20-3569.
- Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021;27:225–28. doi:10.1038/s41591-020-1124-9.
- GHO. https://www.who.int/data/gho .
- Zambia (COVID-19) General Dashboard. https://rtc-planning.maps.arcgis.com/apps/opsdashboard/index.html#/3b3a01c1d8444932ba075fb44b119b63 .
- Dryhurst S, Schneider CR, Kerr J, Freeman ALJ, Recchia G, van der Bles AM, Spiegelhalter D, Van Der Linden S. Risk perceptions of COVID-19 around the world. J. Risk Res. 2020;23:994–1006. doi:10.1080/13669877.2020.1758193.
- Wise T, Zbozinek TD, Michelini G, Hagan CC, Mobbs D. Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States. R. Soc. Open Sci. 2020;7(9):200742. doi:10.1098/rsos.200742.
- Faasse K, Newby J. Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions. Front Psychol. 2020;11. doi:10.3389/fpsyg.2020.551004.
- Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy. Hum. Vaccines Immunother. 2013;9:1763–73. doi:10.4161/hv.24657.
- Karafillakis E, Larson HJ. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35(37):4840–50. doi:10.1016/j.vaccine.2017.07.061.
- Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J. Fearing the disease or the vaccine: the case of COVID-19. Personal. Individ. Differ. 2021;172:110590. doi:10.1016/j.paid.2020.110590.
- Sauer M, Vasudevan P, Meghani A, Luthra K, Garcia C, Knoll MD, Privor-Dumm L. Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine. 2021;39:1556–64. doi:10.1016/j.vaccine.2021.01.066.
- Population and demographic projections 2011-2035, 2010 Census. 2013.
- Rimer BK, Glanz K; National Cancer Institute (U.S.). Theory at a glance: a guide for health promotion practice. Bethesda, MD: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute. 2005.
- Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines. https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine_deployment-2020.1 .
- Swaney SE, Burns S. Exploring reasons for vaccine-hesitancy among higher-SES parents in Perth, Western Australia. Health Promot J Austr. 2019;30:143–52.
- Bocquier A, Fressard L, Cortaredona S, Zaytseva A, Ward J, Gautier A, Peretti-Watel P, Verger P. Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: a nationwide cross-sectional study. Vaccine. 2018;36:7666–73. doi:10.1016/j.vaccine.2018.10.085.
- Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health. 2020;5:e004206.
- Wang Y, McKee M, Torbica A, Stuckler D. Systematic literature review on the spread of health-related misinformation on social media. Soc Sci Med. 2019;240:112552. doi:10.1016/j.socscimed.2019.112552.
- WHO | implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia. WHO. http://www.who.int/bulletin/volumes/96/2/16-189241/en/ doi:10.2471/BLT.16.189241 .
- Njuguna HN, Yusuf N, Raza AA, Ahmed B, Tohme RA. Progress toward maternal and neonatal tetanus elimination — worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep. 2020;69:515–20. doi:10.15585/mmwr.mm6917a2.
- Caserotti M, Girardi P, Rubaltelli E, Tasso A, Lotto L, Gavaruzzi T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med. 2021;272:113688. doi:10.1016/j.socscimed.2021.113688.